Cargando…
Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data
BACKGROUND: Eltrombopag has an off-label indication for haematopoietic cell transplantation in patients experiencing delayed thrombocyte recovery and/or thrombocytopaenia. AIMS: To present our centre’s experience of using this agent not only for post- haematopoietic cell transplantation thrombocytop...
Autores principales: | Kırcalı, Ekin, Cengiz Seval, Güldane, Öztürk, Cemaleddin, Yılmaz, Hülya, Koyun, Derya, Civriz Bozdağ, Sinem, Toprak, Selami Koçak, Topçuoğlu, Pervin, Arslan, Önder, Özcan, Muhit, Demirer, Taner, İlhan, Osman, Gürman, Günhan, Beksaç, Meral, Kurt Yüksel, Meltem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874246/ https://www.ncbi.nlm.nih.gov/pubmed/36571427 http://dx.doi.org/10.4274/balkanmedj.galenos.2022.2022-2-48 |
Ejemplares similares
-
Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center
por: Cengiz Seval, Guldane, et al.
Publicado: (2023) -
Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?
por: Kırcalı, Ekin, et al.
Publicado: (2022) -
Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors
por: Narlı Özdemir, Zehra, et al.
Publicado: (2021) -
P28: RESPONSE AND VACCINATION STATUS OR LACK OF IMMUNOPARESIS ARE ASSOCIATED WITH BETTER OUTCOME FOLLOWING COVID-19 INFECTION AMONG PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE ON 110 PATIENTS
por: Seval, Guldane Cengiz, et al.
Publicado: (2022) -
PB2213: RETROSPECTIVE ANALYSIS OF 45 UNSELECTED PATIENTS WITH HISTIOCYTOSIS CONFIRMS PROGNOSTIC RELEVANCE OF ORGAN INVOLVEMENT: SINGLE‐CENTER EXPERIENCE
por: Yilmaz, Hulya, et al.
Publicado: (2023)